Journal Guide

Oncologie est la revue francophone de référence pour la formation continue des oncologues.Elle apporte, dans une approche multidisciplinaire, des réponses synthétiques à des questions qui se posent dans la pratique quotidienne, à travers des dossiers thématiques réunissant les meilleurs experts et des rubriques récurrentes (DPC, Revue de presse, Psycho-Oncologie, Soins de support, Sénologie…).Oncologie fait le lien entre tous ceux qui font avancer la cancérologie : biologistes, thérapeutes, épidémiologistes, pathologistes, diagnosticiens... et ceux sur le terrain : cancérologues médicaux, radiothérapeutes, chirurgiens, spécialistes d'organe, spécialistes des soins de supports, psychologues, généralistes... Dans cette perspective, Oncologie publie, après soumission au comité de lecture, des revues générales, des articles originaux et de synthèse, des outils DPC et des recommandations et référentiels (Recommandations de Saint-Paul-de-Vence sur le cancer du sein et les soins de supp

The field of haemostasis and thrombosis has witnessed significant developments during the last few decades. While the upcoming of biochemistry, cell biology and later of molecular biology as new research tools has constantly been reflected in the journal, it nevertheless continues to devote many of its pages to traditional clinical pathophysiology.The journal features original contributions reporting the latest findings on the pathology, physiology and biochemistry of haemorrhagic disease and thrombosis as well as on their diagnosis and treatment. In addition to in-depth studies of such topics as blood coagulation factors, fibrinolysis, platelets and vascular biology, readers will find extensive data on clinical results with heparin, oral anticoagulants and newer anti-thrombotics.These experimental and clinical investigations are supported by occasional authoritative reviews to make the journal a full record of current research on thrombosis and haemostasis and its clinical implications.

* Biological Abstracts® (Thomson ISI) * BIOSIS Previews® (Thomson ISI) * Biotechnology & Bioengineering Abstracts (CSA/CIG) * Biowizard (Biowizard) * CAB Abstracts® (CABI) * Cambridge Scientific Abstracts (CSA/CIG) * Chemical Abstracts Service/SciFinder (ACS) * CSA Biological Sciences Database (CSA/CIG) * CSA Environmental Sciences & Pollution Management Database (CSA/CIG) * Current Awareness in Biological Sciences (Elsevier) * Current Contents®/Life Sciences (Thomson ISI) * EMBASE/Excerpta Medica (Elsevier) * Google Scholar * Index Copernicus (IC) * Index Medicus/MEDLINE/PubMed (NLM) * Journal Citation Reports/Science Edition (Thomson ISI) * PASCAL Database (INIST/CNRS) * Reference Update (Thomson ISI) * Science Citation Index Expanded® (Thomson ISI) * Science Citation Index® (Thomson ISI) * SCOPUS (Elsevier).

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Oncology Research and Treatment offers an interdisciplinary forum for cancer research and treatment. Peer-reviewed original and review articles cover a wide range of aspects in medical hematology and oncology, surgical, gynecological, pediatric, and urological oncology, dermatological oncology, diagnostics, radiation oncology, psychological care, pathology, clinical-translational oncology, and oncological rehabilitation. Oncology Research and Treatment is addressed to clinicians and practitioners working and researching in the field of hematology and oncology.
The focus of Oncology Research and Treatment is to report clinical and translational research. Basic research is not in the scope of the journal.

Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes):• Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules• Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention• Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading• Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer• Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care.• Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.

Pathology & Oncology Research (POR) is an interdisciplinary journal at the interface of pathology and oncology, including the preclinical and translational research, diagnostics and therapy. Furthermore, POR offers an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments in its focused biomedical fields which span the gap between basic research and clinical medicine. A special aim of POR is to promote publishing activity in pathology and oncology of colleagues in the Central and East European region. The journal will interest pathologists, and a broad range of experimental and clinical oncologists, and related experts. Pathology & Oncology Research is supported by distinguished international advisory board and the Arányi Foundation for modern pathology.

Pediatric Blood & Cancer will publish in print and online, the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood, including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.